The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study
13.03.2024 - Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, 'Next-Generation ... Seite 1
Source: wallstreet-online.de